U.S. CDMRP – Prostate Cancer Research Program (PCRP)
Event details
| Date | 08.08.2025 |
| Category | Conferences - Seminars |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2025 Prostate Cancer Research Program (PCRP) Awards. Several award programs are available:
Clinical Consortium Award: $7,600,000
Idea Development Award: $1,2 – 1,5M
Duration:
Clinical Consortium Award: 4 years
Idea Development Award: 3-4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 08 August 2025, 5:00 p.m. Eastern time
Full Application Deadline: 29 August 2025, 5:00 p.m. Eastern time
Further information:
- The Clinical Consortium Award provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute phase 2 or phase 2-linked phase 1 (phase 1/2) prostate cancer clinical trials. These trials will include investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer relevant to the FY25 PCRP Overarching Challenges. Support from this award is directed toward consortium infrastructure needs rather than direct support of the research itself.
- The Idea Development Award intends to support new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission.
Clinical Consortium Award: $7,600,000
Idea Development Award: $1,2 – 1,5M
Duration:
Clinical Consortium Award: 4 years
Idea Development Award: 3-4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 08 August 2025, 5:00 p.m. Eastern time
Full Application Deadline: 29 August 2025, 5:00 p.m. Eastern time
Further information:
- To find the full program announcements and to start your pre-application see here
- A useful summary of each call can be found here
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
- Grants.gov Funding Opportunity Numbers:
- Clinical Consortium Award: HT942525PCRPCCA
- Idea Development Award: HT942525PCRPIDA
Practical information
- General public
- Free
Contact
- research@epfl.ch